Article
Recent highlights on Omicron as a new SARS-COVID-19 variant: evolution, genetic mutation, and future perspectives.
Journal of drug targeting - 1 Jul 2022
Khairnar Pooja, Soni Mukesh, Handa Mayank, Riadi Yassine, Kesharwani Prashant, Shukla Rahul
Abstract excerpt
COVID-19 has affected the lives of billions of people and is a causative agent for millions of deaths. After 23 months of the first reported case of COVID-19, on 25th November 2020, a new SARS-COVID-19 variant, i.e. Omicron was reported with a WHO tagline of VoC that trembled the world with its infectivity rate. This fifth VoC raised the concern about neutralising ability and adequate control of SARS-COVID-19...
Topics
Join the communities discussing this publication.